
Sign up to save your podcasts
Or


Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.

91,005 Listeners

38,931 Listeners

112,214 Listeners

8,526 Listeners

99,744 Listeners

9,238 Listeners

41 Listeners

187 Listeners

66 Listeners

29 Listeners

2 Listeners

154 Listeners

1,211 Listeners

3,644 Listeners